Larimar Therapeutics (LRMR) Gains from Sales and Divestitures: 2019
- Larimar Therapeutics' Gains from Sales and Divestitures was N/A to $15,267 in Q4 2019 from the same period last year, while for Dec 2019 it was $15,267, marking a year-over-year change of. This contributed to the annual value of $15,267 for FY2019, which is N/A change from last year.
- Per Larimar Therapeutics' latest filing, its Gains from Sales and Divestitures stood at $15,267 for Q4 2019.
- Larimar Therapeutics' Gains from Sales and Divestitures' 5-year high stood at $15,267 during Q4 2019, with a 5-year trough of $15,267 in Q4 2019.
- Moreover, its 1-year median value for Gains from Sales and Divestitures was $15,267 (2019), whereas its average is $15,267.
